Business Wire

Legora Raises $150 Million Series C to Accelerate Global Rollout of Its AI Platform for Legal Professionals

Share

Legora, the collaborative AI platform for lawyers, today announced the completion of a Series C round of $150 million at a $1.8 billion valuation, led by Bessemer Venture Partners, with significant investment from existing investors ICONIQ, General Catalyst, Redpoint Ventures, Benchmark, and Y Combinator, to accelerate its global expansion and growing product roadmap.

The funding round takes place against a backdrop of rapidly increasing demand for Legora’s AI-powered platform for legal professionals over the past six months. Since May 2025, Legora’s customer base has grown from 250 to over 400, while the number of markets served has doubled from 20 to more than 40.

Legora now partners with many of the world’s most prestigious enterprises and law firms – including Linklaters, Cleary Gottlieb, Goodwin, and MinterEllison – not just as customers, but as strategic collaborators. Tens of thousands of legal professionals use Legora every day to review and research with precision, draft smarter, and collaborate seamlessly.

Max Junestrand, CEO and co-founder of Legora, said:
“We are seeing astronomical demand for our product. Legal professionals across the globe are adopting AI into their work at an unprecedented rate, and I could not be more proud of supporting our customers on this journey. I’m grateful for the strong backing of our investors, which enables us to execute on our vision: enabling the lawyer of the future and seamless collaboration between machine and human intelligence.”

Legora’s success is driven by its collaborative approach to developing and embedding AI. More than a platform, Legora is a trusted partner to its clients – working side by side from the very first interaction through full-scale rollout and beyond. This ensures solutions that are seamlessly aligned with client needs and embraced across entire organizations, driving immediate impact and lasting transformation in the legal profession.

“Legora exemplifies how the most transformative AI companies fundamentally reimagine how work gets done – they've built not just another legal tech tool, but a collaborative AI platform that elevates the practice of law itself,” said Sameer Dholakia, partner, Bessemer Venture Partners. “Max and his team's customer-obsessed approach and exceptional product velocity position Legora to lead the AI transformation of the trillion-dollar legal services industry.”

With offices in Stockholm, London, New York, Denver, and Sydney, Legora has built a team of nearly 200 legal experts and technologists. In the year ahead, the company aims to more than double in size and establish additional global hubs, strengthening its ability to meet the needs of an expanding international client base.

Max Junestrand added:
“Legora is quickly becoming the go-to partner for legal professionals worldwide – making their work easier, more rewarding, and more profitable. We’ve made great progress, but we are only getting started, and executing on our vision will demand relentless focus and hard work from the entire team. We're excited for the next stage of our journey and the opportunity to create long-lasting impact across the legal profession.”

About Legora

Legora’s collaborative AI platform helps lawyers review and research faster, draft smarter, and advise with precision. Backed by world-class investors such as Bessemer Venture Partners, ICONIQ, General Catalyst, Redpoint Ventures, Benchmark, and Y Combinator, Legora serves more than 400 leading law firms and in-house legal teams in over 40 markets.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251030974157/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Svante Celebrates 18 Years of Carbon Management Innovation with Historic Milestones in 202530.10.2025 17:25:00 CET | Press release

Svante Technologies Inc. (Svante), a global leader in carbon capture and removal solutions, proudly marks its 18th anniversary this month, celebrating nearly two decades of pioneering industrial carbon management technology. This year has been one of the most transformative in Svante’s history, defined by bold innovation, strategic partnerships, and the commissioning of the world’s first commercial manufacturing facility for solid sorbent-based carbon capture and removal filters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030974500/en/ Founded in 2007 with a vision to revolutionize how the world manages carbon dioxide emissions, Svante has grown into a cornerstone of the global carbon management industry. In 2025, that vision took a monumental leap forward with the launch of the Redwood Facility in Burnaby, BC — a 141,000-square-foot Centre of Excellence for Carbon Capture and Removal. This first-of-its-kind manufactu

Ireland Unveils Seven New Halloween Experiences30.10.2025 15:00:00 CET | Press release

More celebrations than ever across the island of Ireland – the true Home of Halloween With seven brand-new Halloween hubs or experiences launching across the island this month, Ireland has truly become the ultimate destination to celebrate Halloween in 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251022209535/en/ Derry Halloween Festival, County Derry~Londonderry Ireland’s Halloween Season Rooted in the ancient Celtic festival of Samhain, Halloween originated in Ireland more than 2,000 years ago and, this year, the island of Ireland is expanding its celebration like never before. With over 340 events planned across the island to celebrate this year, Halloween in Ireland is fast becoming a bucket-list travel experience. Seven new Halloween hubs join existing flagship events across the island of Ireland including the Púca Festival in County Meath and Derry Halloween in Derry-Londonderry which together welcomed over 169

Staloral® Birch Phase III Study Successfully Meets Primary Endpoint, Demonstrating Efficacy in Children and Adolescents30.10.2025 14:56:00 CET | Press release

Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of Staloral® Birch in children and adolescents with birch pollen-induced allergic rhino-conjunctivitis (ARC), with or without asthma, has successfully achieved its primary endpoint. The trial enrolled 553 children aged 5 -17 years with moderate to severe birch pollen-induced ARC, with or without asthma, across 64 sites in 12 European countries and assessed the efficacy and safety of Staloral® birch 300IR daily maintenance dose administered pre-and co-seasonally over two consecutive birch pollen seasons. The YOBI study successfully met its primary endpoint, demonstrating the efficacy of Staloral® Birch in a paediatric population (5-17) with a 41% improvement in the ARC total combined score during the second pollen season compared to placebo. These results were highly statistically significant

Debiopharm Forges AI-powered Alliance With NetTargets to Pioneer Dual-payload ADCs Against Drug-resistant Cancers30.10.2025 14:00:00 CET | Press release

An Alliance to Combat Resistance: Debiopharm and NetTargets will collaborate to develop next-generation, dual-payload Antibody-Drug Conjugates (ADCs) designed to overcome acquired resistance mechanisms in difficult-to-treat cancers. AI-Powered Precision: The collaboration combines NetTargets' proprietary AI discovery platform—to identify synergistic drug pairings—with Debiopharm’s MLINK Duo technology for coordinated delivery of two distinct warheads on a single ADC. Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company dedicated to developing innovative therapies that respond to high unmet medical needs, today announced a strategic research collaboration with NetTargets (www.net-targets.com), a South Korean biotech company specializing in AI-enhanced systems biology for drug discovery, to rationally design and advance the discovery of novel, synergistic drug combinations for Debiopharm’s next-generation Antibody-Drug Conjugates (ADCs). This allianc

Bending Spoons Raises $710M for Continued Investment and Growth30.10.2025 14:00:00 CET | Press release

Bending Spoons, one of Europe’s leading technology companies, today announced it has raised $710 million in equity at a pre-money valuation of $11 billion. The round was led by accounts advised by T. Rowe Price Investment Management, Inc., with participation from Baillie Gifford, Cox Enterprises, Durable Capital Partners, Fidelity Management & Research Company, Foxhaven Asset Management, and Radcliff, among others. Goldman Sachs International acted as sole placement agent and Clifford Chance served as legal advisor to the transaction. Notarial advisory services were provided by ZNR Notai. “This moment is a validation of a decade’s worth of work and it serves as an important recognition of what we’ve accomplished at Bending Spoons so far. We remain early in our journey and have ambitious plans for continued investment and growth,” shares Luca Ferrari, co-founder and CEO of Bending Spoons. “We’re proud to bring on some of the world’s finest investors who believe in our approach to value

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye